FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169682079> ?p ?o ?g. }

• W3169682079 endingPage "e16255" @default.
• W3169682079 startingPage "e16255" @default.
• W3169682079 abstract "e16255 Background: Venous thromboembolism (VTE) is a common complication in patients with pancreatic cancer (PC). Incidence of major bleeding and clinically relevant non-major bleeding is 14%-20% in patients with cancer who receive anticoagulation therapy (AT). Whipple procedure is a complex surgical intervention offering potential cure in patients with resectable PC; however, surgery can affect drug absorption, which may reduce effectiveness of AT or exacerbate drug related adverse events. Our aim was to assess incidence of bleeding in PC patients who had whipple procedure with subsequent VTE. Methods: Retrospective analysis of medical records for all adult patients with PC who underwent whipple procedure and developed VTE (between July 1, 2010, and July 1, 2020) at Henry Ford Hospital was performed. Multiple variables and outcomes were analyzed by two-group comparisons, univariate analysis, and Cox regression. Results: A total of 32 patients were included in the analysis. The mean (standard deviation [SD]) age was 67.4 (11 y) years, 16 (50%) patients were men, and 16 (50%) were women, (20 [63%] White; 11 [34%] Black; 1 [3%] Asian). The median Khorana score was 3 (range, 2–4). Of the 32 patients, 6 (19%) had upper extremity VTE, 11 (34%) had lower extremity VTE, 10 (31%) had a pulmonary embolism, 7 (22%) had intra-abdominal VTE, and 7 (22%) had recurrent VTE. All patients with upper extremity VTE had a peripherally inserted central catheter (PICC) or a venous port at the time of VTE diagnosis. Most of the patients (28 or 88%) received AT. Whereas 13 (41%) patients had at least one bleeding episode, 19 (59%) had no bleeding. Twenty-two (68%) patients did not need PRBC transfusion, while 4 (13%) patients required > 4 units packed red blood cell transfusion. No significant association between bleeding and AT was observed ( p = .590). Patients with a bleeding event had lower hemoglobin levels ( p = .030) and were more likely to receive blood transfusion ( p = .005). Cox regression analysis did not show patient age, ethnicity, type of AT used, recurrent VTE, and neoadjuvant chemotherapy treatment to be significantly associated with bleeding or death. A total of 14 (44%) patients were alive at the time of analysis. Conclusions: In patients with PC and VTE who received AT after whipple procedure, the incidence of bleeding was higher than what has been reported in patients with cancer in general, regardless of type of AT administration. Patients with central venous catheters might be at increased risk of upper extremity VTE and this subset of patients may benefit from various risk reducing strategies. Caution is recommended while managing AT in this complex patient population, and more studies are needed to assess factors specifically associated with AT and bleeding after whipple procedure." @default.
• W3169682079 created "2021-06-22" @default.
• W3169682079 creator A5010706893 @default.
• W3169682079 creator A5015987197 @default.
• W3169682079 creator A5031629235 @default.
• W3169682079 creator A5033510736 @default.
• W3169682079 creator A5043799925 @default.
• W3169682079 creator A5053365022 @default.
• W3169682079 creator A5075004313 @default.
• W3169682079 creator A5083535383 @default.
• W3169682079 date "2021-05-20" @default.
• W3169682079 modified "2023-10-17" @default.
• W3169682079 title "Anticoagulation outcomes in patients with venous thromboembolism following Whipple surgery for pancreatic cancer: Single center experience." @default.
• W3169682079 doi "https://doi.org/10.1200/jco.2021.39.15_suppl.e16255" @default.
• W3169682079 hasPublicationYear "2021" @default.
• W3169682079 type Work @default.
• W3169682079 sameAs 3169682079 @default.
• W3169682079 citedByCount "0" @default.
• W3169682079 crossrefType "journal-article" @default.
• W3169682079 hasAuthorship W3169682079A5010706893 @default.
• W3169682079 hasAuthorship W3169682079A5015987197 @default.
• W3169682079 hasAuthorship W3169682079A5031629235 @default.
• W3169682079 hasAuthorship W3169682079A5033510736 @default.
• W3169682079 hasAuthorship W3169682079A5043799925 @default.
• W3169682079 hasAuthorship W3169682079A5053365022 @default.
• W3169682079 hasAuthorship W3169682079A5075004313 @default.
• W3169682079 hasAuthorship W3169682079A5083535383 @default.
• W3169682079 hasConcept C120665830 @default.
• W3169682079 hasConcept C121332964 @default.
• W3169682079 hasConcept C121608353 @default.
• W3169682079 hasConcept C126322002 @default.
• W3169682079 hasConcept C141071460 @default.
• W3169682079 hasConcept C144301174 @default.
• W3169682079 hasConcept C195910791 @default.
• W3169682079 hasConcept C197934379 @default.
• W3169682079 hasConcept C2776265017 @default.
• W3169682079 hasConcept C2778959117 @default.
• W3169682079 hasConcept C2780011451 @default.
• W3169682079 hasConcept C2780210213 @default.
• W3169682079 hasConcept C2780868729 @default.
• W3169682079 hasConcept C38180746 @default.
• W3169682079 hasConcept C61511704 @default.
• W3169682079 hasConcept C71924100 @default.
• W3169682079 hasConcept C81182388 @default.
• W3169682079 hasConceptScore W3169682079C120665830 @default.
• W3169682079 hasConceptScore W3169682079C121332964 @default.
• W3169682079 hasConceptScore W3169682079C121608353 @default.
• W3169682079 hasConceptScore W3169682079C126322002 @default.
• W3169682079 hasConceptScore W3169682079C141071460 @default.
• W3169682079 hasConceptScore W3169682079C144301174 @default.
• W3169682079 hasConceptScore W3169682079C195910791 @default.
• W3169682079 hasConceptScore W3169682079C197934379 @default.
• W3169682079 hasConceptScore W3169682079C2776265017 @default.
• W3169682079 hasConceptScore W3169682079C2778959117 @default.
• W3169682079 hasConceptScore W3169682079C2780011451 @default.
• W3169682079 hasConceptScore W3169682079C2780210213 @default.
• W3169682079 hasConceptScore W3169682079C2780868729 @default.
• W3169682079 hasConceptScore W3169682079C38180746 @default.
• W3169682079 hasConceptScore W3169682079C61511704 @default.
• W3169682079 hasConceptScore W3169682079C71924100 @default.
• W3169682079 hasConceptScore W3169682079C81182388 @default.
• W3169682079 hasIssue "15_suppl" @default.
• W3169682079 hasLocation W31696820791 @default.
• W3169682079 hasOpenAccess W3169682079 @default.
• W3169682079 hasPrimaryLocation W31696820791 @default.
• W3169682079 hasRelatedWork W11486355 @default.
• W3169682079 hasRelatedWork W14203453 @default.
• W3169682079 hasRelatedWork W14993076 @default.
• W3169682079 hasRelatedWork W20983443 @default.
• W3169682079 hasRelatedWork W21531011 @default.
• W3169682079 hasRelatedWork W3241159 @default.
• W3169682079 hasRelatedWork W4294805 @default.
• W3169682079 hasRelatedWork W5244146 @default.
• W3169682079 hasRelatedWork W5465444 @default.
• W3169682079 hasRelatedWork W8568283 @default.
• W3169682079 hasVolume "39" @default.
• W3169682079 isParatext "false" @default.
• W3169682079 isRetracted "false" @default.
• W3169682079 magId "3169682079" @default.
• W3169682079 workType "article" @default.